|
Evaluation of Assays for Antibody to Hepatitis E
Virus by a Serum Panel
References
1. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES,
Braginsky DM, Savinov AP, Poleschuk VF. Evidence for a virus in
non-A, non-B hepatitis transmitted via the fecal-oral route.
Intervirology 1983; 20: 23-31[ [ Link previously at www.ncbi.nlm.nih.gov ]].
2. Kane MA, Bradley DW, Shrestha SM, Maynard JE, Cood EH, Mishra
PP, Joshi DD. Epidemic non-A, non-B hepatitis in Nepal: recovery of
a possible etiologic agent and transmission studies in marmosets.
JAMA 1984; 252: 3140-3145[ [ Link previously at www.ncbi.nlm.nih.gov ]].
3. Krawczynski K, Bradley DW. Enterically transmitted non-A,
non-B hepatitis: identification of virus-associated antigen in
experimentally infected cynomolgus macaques. J Infect Dis 1989;
159: 1042-1049[
Medline].
4. Purdy MA, Carson D, McCaustland KA, Bradley DW, Beach MJ,
Krawczynski K. Viral specificity of hepatitis E virus antigens
identified by fluorescent antibody assay using recombinant HEV
proteins. J Med Virol 1994; 44: 212-214[ [ Link previously at www.ncbi.nlm.nih.gov ]].
5. Purdy MA, McCaustland KA Krawczynski K, Tam A, Beach MJ,
Tassopoulos NC, et al. Expression of a hepatitis E virus (HEV)-trpE
fusion protein containing epitopes recognized by antibodies in sera
from human cases and experimentally infected primates. Arch Virol
1992;123:335-349.
6. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG,
Alter MJ, et al. Serologic identification of hepatitis E virus
infections i n epidemic and endemic settings. J Med Virol 1992; 36:
246-250[ [ Link previously at www.ncbi.nlm.nih.gov ]].
7. Dawson GJ, Chau KH, Cabal CM, Yarbough PO, Reyes GR,
Mushahwar IK. Solid-phase enzyme-linked immunosorbent assay for
hepatitis E virus IgG and IgM antibodies utilizing recombinant
antigens and synthetic peptides. J Virol Methods 1992; 38:
175-186[ [ Link previously at www.ncbi.nlm.nih.gov ]].
8. Tsarev SA, Tsareva TS, Emerson SU, Kapikian AZ, Ticehurst J,
London W, Purcell RH. ELISA for antibody to hepatitis E virus (HEV)
based on complete open-reading frame-2 protein expressed in insect
cells: identification of HEV infection in primates. J Infect Dis
1993; 168: 369-378[ [ Link previously at www.ncbi.nlm.nih.gov ]].
9. Uchida T, Aye TT, Ma X, Iida F, Shikata T, Ichikawa M, et al.
An epidemic of hepatitis E in Yangon of Myanmar: antibody assay and
animal transmission of the virus. Acta Pathol Jpn 1993; 43:
94-98[ [ Link previously at www.ncbi.nlm.nih.gov ]].
10. Favorov MO, Khudyakov YE, Fields HA, Khudyakova NS, Padhye
N, Alter MJ, et al. Enzyme immunoassay for the detection of
antibody to hepatitis E virus based on synthetic peptides. J Virol
Methods 1994; 46: 237-250[ [ Link previously at www.ncbi.nlm.nih.gov ]].
11. Li F, Zhuang H, Kolivas S, Locarnini SA, Anderson DA.
Persistent and transient antibody responses to hepatitis E virus
detected by western immunoblot using open reading frame 2 and 3 and
glutathione S-transferase fusion proteins. J Clin Microbiol 1994;
32: 2060-2066[
Abstract].
12. Yarbough PO, Tam AW, Gabor K, Garza E, Moeckli RA, Palings
I, et al. Assay development of diagnostic tests for hepatitis E.
In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis
and liver disease, Tokyo: Springer-Verlag, 1994:367-370.
13. Coursaget P, Depril N, Buisson Y, Molinie C, Roue R.
Hepatitis type E in a French population: detection of anti-HEV by a
synthetic peptide-based enzyme-linked immunosorbent assay. Res
Virol 1994; 145: 51-57[ [ Link previously at www.ncbi.nlm.nih.gov ]].
14. Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK.
Protracted viremia during acute sporadic hepatitis E virus
infection. Gastroenterology 1995; 108: 225-230[
Abstract].
15. Favorov MO, Khudyakov YE, Mast EE, Yashina TL, Shapiro CN,
Khudyakova NS, et al. IgM and IgG antibody to hepatitis E virus
(HEV) detected by enzyme immunoassay based on an HEV-specific
artificial recombinant mosaic protein. J Med Virol 1996; 50:
50-58[ [ Link previously at www.ncbi.nlm.nih.gov ]].
16. Panda SK, Nanda SK, Zafrullah M, Ansari I, Ozdener MH,
Jameel S. An Indian strain of hepatitis E virus (HEV): cloning,
sequence, and expression of structural region and antibody
responses in sera from individuals from an area of high-level HEV
endemicity. J Clin Microbiol 1995; 33: 2653-2659[
Abstract].
17. Bryan JP, Tsarev SA, Iqbal M, Ticehurst J, Emerson S, Ahmed
A, et al. Epidemic hepatitis E in Pakistan: patterns of serologic
response and evidence that antibody to hepatitis E virus protects
against disease. J Infect Dis 1994; 170: 517-521[ [ Link previously at www.ncbi.nlm.nih.gov ]].
18. Heath TC, Burrow JN, Currie BJ, Bowden FJ, Fisher DA,
Demediuk BH, et al. Locally acquired hepatitis E in the Northern
Territory of Australia. Med J Aust 1995; 162: 318-319[ [ Link previously at www.ncbi.nlm.nih.gov ]].
19. Zanetti AR, Dawson GJ. Hepatitis type E in Italy: a
seroepidemiological survey. J Med Virol 1994; 42: 318-320[ [ Link previously at www.ncbi.nlm.nih.gov ]].
20. Coursaget P, Depril N, Buisson Y, Molinie C, Roue R.
Hepatitis E in a French population: detection of anti-HEV by a
synthetic peptide-based enzyme-linked immunosorbent assay. Res
Virology 1994; 145: 51-57[ [ Link previously at www.ncbi.nlm.nih.gov ]].
21. Tassopoulos NC, Krawczynski K, Hatzakis A, Katsoulidou A,
Delladetsima I, Koutelou MG, Trichopoulos D. Case report: role of
hepatitis E virus in the etiology of community-acquired non-A,
non-B hepatitis in Greece. J Med Virol 1994; 42: 124-128[ [ Link previously at www.ncbi.nlm.nih.gov ]].
22. Sallie R, Silva AE, Purdy M, Smith H, McCaustland K, Tibbs
C, et al. Hepatitis C and E in non-A non-B fulminant hepatic
failure: a polymerase chain reaction and serologic study. J Hepatol
1994; 20: 580-588[ [ Link previously at www.ncbi.nlm.nih.gov ]].
23. Zaaijer HL, Kok M, Lelie PN, Timmerman RJ, Chau K, van der
Pal HJH. Hepatitis E in the Netherlands: imported and endemic.
Lancet 1993; 341: 826[ [ Link previously at www.ncbi.nlm.nih.gov ]].
24. Mast EE, Kuramoto IK, Favorov MO, Schoenig VR, Burkholder
BT, Shapiro CN, Holland PV. Prevalence and risk factors for
antibody to hepatitis E virus seroreactivity among blood donors in
Northern California. J Infect Dis 1997; 176: 34-40[ [ Link previously at www.ncbi.nlm.nih.gov ]]
25.Paul DA, Knigge MF, Ritter A, Gutierrez R, Pilot-Matiias T,
Chau KH, Dawson GW. Determination of hepatitis E virus
seroprevalence by using recombinant fusion proteins and synthetic
peptides. J Infect Dis 1994; 169: 801-806[ [ Link previously at www.ncbi.nlm.nih.gov ]].
26. Zanetti AR, Dawson GJ, the Study Group of Hepatitis E.
Hepatitis type E in Italy: a seroepidemiological survey. J Med
Virol 1994; 42: 318-320[ [ Link previously at www.ncbi.nlm.nih.gov ]].
27. Thomas DL, Yarbough PO, Vlahov D, Tsareva SA, Nelson KE,
Saah AJ, Purcell RH. Seroreactivity to hepatitis E virus in areas
where the disease is not endemic. J Clin Microbiol 1997; 35:
1244-1247[
Abstract].
28. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE,
Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing
of the full-length viral genome. Virology 1991; 185: 120-131[
Medline].
29. Huang CC, Nguyen D, Fernandez J, Yun KY, Fry KE, Bradley DW,
et al. Molecular cloning and sequencing of the Mexico isolate of
hepatitis E virus (HEV). Virology 1992; 191: 550-558[ [ Link previously at www.ncbi.nlm.nih.gov ]].
30. Tsarev SA, Emerson SU, Reyes GR, Tsareva TS, Letgers LJ,
Malik IA, et al. Characterization of a prototype strain of
hepatitis E virus. Proc Natl Acad Sci U S A 1992; 89: 559-563[ [ Link previously at www.ncbi.nlm.nih.gov ]].
31. Aye TT, Uchida T, Ma XZ, Iida F, Shikata T, Zhuang H, Win
KM. Complete nucleotide sequence of a hepatitis E virus isolated
from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res
1992; 20: 3512[ [ Link previously at www.ncbi.nlm.nih.gov ]].
32. Bradley DW, Andjaparidze A, Cook EH, McCaustland K, Balayan
M, Stetler H, et al. Aetiological agent of enterically transmitted
non-A, non-B hepatitis. J Gen Virol 1988; 69: 731-738[ [ Link previously at www.ncbi.nlm.nih.gov ]].
33. Krawczynski K. Antigens and antibodies of hepatitis E virus
infection in experimental primate models and man. In: Hollinger FB,
Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease,
Baltimore: Williams & Wilkins, 1991:517-521.
34. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva
TS, et al. A novel virus in swine is closely related to the human
hepatitis E virus. Proc Natl Acad Sci U S A 1997; 94: 9860-9865[
Abstract/Full Text].
Return To Article
|
